Pfizer on Tuesday reaffirmed its outlook for the year, and announced another round of cost cuts as the beleaguered drugmaker ...

Scientists reveal what vaccines are really capable of As new COVID-19 variants continue to emerge, widespread concerns have ...

Pfizer said it still expects adjusted 2025 profit of $2.80 a share to $3 a share, while analysts expect full-year earnings of $2.94 a share. Pfizer also projected 2025 revenue of $61 billion to $64 ...

The cuts aim to help Pfizer recover from the rapid decline of its Covid business and stock price over the last few years, and ...

(Reuters) -U.S. drugmaker Pfizer reported first-quarter profit above Wall Street estimates on Tuesday, helped by cots cuts ...

Receiving a COVID-19 booster vaccine in the same arm as the first vaccine dose leads to a faster, more effective immune ...

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...

Scientists have uncovered why vaccines can elicit a stronger immune response if they are administered in the same arm.

When it comes to getting the most out of a vaccine, arm consistency can make a difference. Some studies suggest that getting ...

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...